Contract development and manufacturing organizations (CDMOs) are at the forefront of integrating artificial intelligence (AI) and continuous manufacturing to enhance efficiency, scalability, and compliance in parenteral drug production. AI-driven automation allows CDMOs to optimize formulation development, enhance real time process monitoring, and ...
read more